A Multicenter Trial of the Efficacy and Safety of Diclegis for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2019
Price : $35 *
At a glance
- Drugs Doxylamine/pyridoxine (Primary)
- Indications Morning sickness
- Focus Therapeutic Use
- Sponsors Duchesnay Inc
- 14 Apr 2017 Planned End Date changed from 1 Dec 2017 to 1 Sep 2017.
- 14 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Jun 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.